Bayer Aktiengesellschaft (OTCMKTS:BAYRY - Get Free Report) issued its quarterly earnings data on Wednesday. The company reported $0.28 earnings per share (EPS) for the quarter, hitting analysts' consensus estimates of $0.28, Zacks reports. Bayer Aktiengesellschaft had a positive return on equity of 16.90% and a negative net margin of 2.02%. The business had revenue of $12.63 billion during the quarter, compared to analyst estimates of $11.38 billion. Bayer Aktiengesellschaft updated its FY 2025 guidance to 4.800-5.330 EPS.
Bayer Aktiengesellschaft Stock Performance
BAYRY stock traded down $0.35 on Friday, reaching $6.36. The company's stock had a trading volume of 1,085,990 shares, compared to its average volume of 1,040,066. The firm has a fifty day moving average of $5.56 and a two-hundred day moving average of $6.26. The company has a debt-to-equity ratio of 1.19, a current ratio of 1.32 and a quick ratio of 0.81. The company has a market capitalization of $24.99 billion, a P/E ratio of -24.46 and a beta of 1.02. Bayer Aktiengesellschaft has a 52 week low of $4.79 and a 52 week high of $8.58.
Bayer Aktiengesellschaft Company Profile
(
Get Free Report)
Bayer Aktiengesellschaft, together its subsidiaries, operates as a life science company worldwide. It operates through Pharmaceuticals, Consumer Health, and Crop Science segments. The Pharmaceuticals segment offers prescription products primarily for cardiology and women's health care; specialty therapeutics in the areas of oncology, hematology, and ophthalmology; and diagnostic imaging equipment and digital solutions, and contrast agents, as well as cell and gene therapy.
See Also
Before you consider Bayer Aktiengesellschaft, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Bayer Aktiengesellschaft wasn't on the list.
While Bayer Aktiengesellschaft currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Wondering where to start (or end) with AI stocks? These 10 simple stocks can help investors build long-term wealth as artificial intelligence continues to grow into the future.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
